207 related articles for article (PubMed ID: 17534446)
1. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells.
Sroka IC; Nagle RB; Bowden GT
Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.
Zhang Z; Song T; Jin Y; Pan J; Zhang L; Wang L; Li P
Int J Gynecol Cancer; 2009 Aug; 19(6):998-1003. PubMed ID: 19820359
[TBL] [Abstract][Full Text] [Related]
3. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
6. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
Park CH; Chung JH
J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
[TBL] [Abstract][Full Text] [Related]
8. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
10. Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway.
Kuo L; Chang HC; Leu TH; Maa MC; Hung WC
J Cell Physiol; 2006 Jun; 207(3):729-34. PubMed ID: 16453304
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
[TBL] [Abstract][Full Text] [Related]
12. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
Sroka IC; McDaniel K; Nagle RB; Bowden GT
Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
[TBL] [Abstract][Full Text] [Related]
13. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.
Takino T; Miyamori H; Watanabe Y; Yoshioka K; Seiki M; Sato H
Cancer Res; 2004 Feb; 64(3):1044-9. PubMed ID: 14871836
[TBL] [Abstract][Full Text] [Related]
14. PDGF-BB-induced MT1-MMP expression regulates proliferation and invasion of mesenchymal stem cells in 3-dimensional collagen via MEK/ERK1/2 and PI3K/AKT signaling.
Sun X; Gao X; Zhou L; Sun L; Lu C
Cell Signal; 2013 May; 25(5):1279-87. PubMed ID: 23415772
[TBL] [Abstract][Full Text] [Related]
15. JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells.
Ispanovic E; Haas TL
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C579-88. PubMed ID: 16672691
[TBL] [Abstract][Full Text] [Related]
16. Activation of two distinct MAPK pathways governs constitutive expression of matrix metalloproteinase-1 in human pancreatic cancer cell lines.
Endo H; Watanabe T; Sugioka Y; Niioka M; Inagaki Y; Okazaki I
Int J Oncol; 2009 Dec; 35(6):1237-45. PubMed ID: 19885545
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
18. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2.
Boyd PJ; Doyle J; Gee E; Pallan S; Haas TL
Am J Physiol Cell Physiol; 2005 Mar; 288(3):C659-68. PubMed ID: 15509661
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration.
Séguin CA; Pilliar RM; Madri JA; Kandel RA
Spine (Phila Pa 1976); 2008 Feb; 33(4):356-65. PubMed ID: 18277865
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Ling Poon S; Lau MT; Hammond GL; Leung PC
Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
